Epidemiology of Helicobacter pylori infection: Disease management implications for peptic ulcer disease

Disease Management and Health Outcomes

Volumn 6, Issue 1, 1999, Pages 9-18

  Malaty, Hoda M ^b   Graham, David Y ^a  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; AMOXICILLIN; ANTIBIOTIC AGENT; BACTERIAL ANTIGEN; BISMUTH CITRATE; BISMUTH SALICYLATE; CLARITHROMYCIN; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; RANITIDINE BISMUTH CITRATE; TETRACYCLINE; UREA;

BREATH ANALYSIS; COLITIS; ENVIRONMENTAL FACTOR; FECES ANALYSIS; GENETIC PREDISPOSITION; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; HYGIENE; MALPRACTICE; PATIENT GUIDANCE; PEPTIC ULCER; POPULATION RESEARCH; RECURRENT DISEASE; REVIEW; UNITED STATES;

EID: 0032840327     PISSN: 11738790     EISSN: None     Source Type: Journal    
DOI: 10.2165/00115677-199906010-00002     Document Type: Article

References (3)

1. Graham DY. Campylobacter pylori and peptic ulcer disease. Gastroenterology 1989; 96: 615-25
2. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 1311-5
3. Tytgat GN, Noach LA, Rauws EA. Helicobacter pylori infection and duodenal ulcer disease. Gastroenterol Clin North Am 1993; 22: 127-39